J
Jens Scholz
Researcher at University of Kiel
Publications - 245
Citations - 7891
Jens Scholz is an academic researcher from University of Kiel. The author has contributed to research in topics: Propofol & Cerebral perfusion pressure. The author has an hindex of 49, co-authored 240 publications receiving 7368 citations. Previous affiliations of Jens Scholz include University of Hamburg.
Papers
More filters
Journal ArticleDOI
Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version
DAS-Taskforce,Ralf Baron,Andreas Binder,R. Biniek,Stephan Braune,Hartmut Buerkle,Peter Dall,Sueha Demirakca,Rahel Eckardt,Verena Eggers,Ingolf Eichler,Ingo Fietze,Stephan Freys,Andreas Fründ,Lars Garten,Bernhard Gohrbandt,Irene Harth,Wolfgang H. Hartl,Hans Jürgen Heppner,Johannes Horter,R. Huth,Uwe Janssens,Christine Jungk,Kristin Maria Kaeuper,Paul Kessler,Stefan Kleinschmidt,Matthias Kochanek,Matthias Kumpf,A. Meiser,Anika Mueller,Maritta Orth,Christian Putensen,Bernd Roth,Michael Schaefer,Rainhild Schaefers,Peter Schellongowski,Monika Schindler,Reinhard Schmitt,Jens Scholz,Stefan Schroeder,Gerhard Schwarzmann,Claudia Spies,Robert Stingele,Peter H. Tonner,Uwe Trieschmann,Michael Tryba,Frank Wappler,Christian Waydhas,Bjoern Weiss,Guido Weisshaar +49 more
TL;DR: This publication is a comprehensive, interdisciplinary, evidence and consensus-based set of level 3 guidelines for intensive care medicine, designed for all ICU professionals, and takes into account all critically ill patient populations.
Journal ArticleDOI
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
TL;DR: Alfentanil has the most rapid analgesic onset and time to peak effect as well as the shortest distribution and elimination half-lives, while the volume of distribution and total body clearance of this agent are smaller when compared with those of fentanyl and sufentanin.
Journal ArticleDOI
Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery.
Rolf Rossaint,Matthias Reyle-Hahn,Jochen Schulte am Esch,Jens Scholz,P. Scherpereel,Benoit Vallet,Francesco Giunta,Monica Del Turco,Wilhelm Erdmann,R. Tenbrinck,A. F. Hammerle,Peter Nagele +11 more
TL;DR: This first randomized controlled multicenter trial on the use of xenon as an inhalational anesthetic confirms that xenon in oxygen provides effective and safe anesthesia, with the advantage of a more rapid recovery when compared with anesthesia using isoflurane–nitrous oxide.
Journal ArticleDOI
Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial
Manfred Blobner,Lars Eriksson,Jens Scholz,Johann Motsch,Giorgio Della Rocca,Martine E. Prins +5 more
TL;DR: Sugammadex achieved significantly faster recovery of neuromuscular function after rocuronium to a TOF ratio of 0.9 compared with neostigmine (Clinicaltrials.gov identifier: NCT00451217).
Journal ArticleDOI
Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.
Frank Wappler,Marko Fiege,Markus Steinfath,Kamayni Agarwal,Jens Scholz,S. Singh,Jakob Matschke,Jochen Schulte am Esch +7 more
TL;DR: The authors recommend performing muscle biopsies for histologic examination and IVCT in patients with ER and screened for genetic abnormalities to shed light on the genetics of MH.